Koyfin Home > Directory > Health Care > Achillion Pharmaceuticals

Achillion Pharmaceuticals Price Chart ACHN

Historical daily share price chart and data for Achillion Pharmaceuticals since 2006 adjusted for splits and dividends. The latest closing price for Achillion Pharmaceuticals as of January 27, 2020 is $6.76.
  • In 2020 the stock opened at $6.07 and closed at $6.76 for a gain of 10% YTD.
  • In 2019 the stock opened at $1.57 and closed at $6.03 for a gain of 74%.
  • In 2018 the stock opened at $2.89 and closed at $1.59 for a loss of -82%.
  • In 2017 the stock opened at $4.15 and closed at $2.88 for a loss of -44%.
View Chart On Koyfin

Achillion Pharmaceuticals Summary

Stock Symbol: ACHN

Achillion Pharmaceuticals Company Info

Achillion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for immune system disorders. Its lead drug candidate is ACH-4471, an inhibitor of factor D that is Phase II clinical trials for patients with paroxysmal nocturnal hemoglobinuria (PNH) and C3 glomerulopathy/immune complex membranoproliferative glomerulonephritis. The company is also developing ACH-5228, a factor D inhibitor that is in Phase I clinical trials; and ACH-5548, a factor D inhibitor, which is in Phase I clinical trials for the treatment of PNH and other complement mediated diseases. It has license agreements with Ora, Inc. for the development and commercialization of ACH-702; and GCA Therapeutics, Ltd for elvucitabine, a nucleoside reverse transcriptase inhibitor for the treatment of hepatitis B infection and human immunodeficiency virus infection. The company was founded in 1998 and is based in Blue Bell, Pennsylvania. As of January 28, 2020, Achillion Pharmaceuticals, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
1637.89 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of ACHN Prices